Role of Homoeopathic medicines in treatment of children with worms.
Phase 2
- Conditions
- Health Condition 1: B770- Ascariasis with intestinal complications
- Registration Number
- CTRI/2024/03/063707
- Lead Sponsor
- Raxitkumar Ramavat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of both sexes & all age groups from 1 to 14 years will be consider.
All socio economic class will be consider.
Exclusion Criteria
Complicated cases with advanced & irreversible pathological
conditions.
Cases with irregular follow ups.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method I will study the effectiveness of Calcarea carbonica, Cina & Sulphur, after prescription changes will be observe. <br/ ><br>Changes in Stool investigation report will be observe.Timepoint: As per case requirements : 2 weeks.
- Secondary Outcome Measures
Name Time Method To prepare a kit of Homoeopathic medicine for treatment of worms.Timepoint: Results seen in 18 months of study.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Calcarea carb., Cina, and Sulphur in treating intestinal Ascariasis in children?
How does the combination of homeopathic Calcarea carb., Cina, and Sulphur compare to standard anthelmintic therapies like albendazole for Ascariasis?
Are there specific biomarkers associated with response to homeopathic treatment in pediatric patients with B770 Ascariasis and intestinal complications?
What adverse events are reported in Phase II trials of homeopathic interventions for helminth infections in children?
What evidence supports the use of homeopathic compounds versus synthetic anthelmintics for managing Ascariasis in high-risk pediatric populations?